Baba Inusa

Professor of paediatric haematology

Area of expertise: sickle cell disease and thalassaemia.

Biography

Graduated MBBS, ABU Zaria, Nigeria 1984, fellowship in paediatrics nigeria (1992) and UK (1995). Consultant East and North Hertfordshire,1997, Guy’s and St Thomas NHS Foundation Trust from 2003 and professor of paediatric haematology, King’s College London from 2019. Lead consultant at Evelina London, Guy’s and St Thomas NHS London

Chair, National Haemoglobinopathy Panel from 2020 leading national Multidisciplinary team meeting of complex patients and business meetings with stakeholders.

His research interest includes newborn screening, stroke and renal impairment in sickle cell disease, with special interest in global haematology leading projects in Africa and global mentor for scientists and clinicians in SCD.

Chair and convenor, academy for sickle cell and thalassaemia (ASCAT) and currently partner with EHA and BSH to run an international annual scientific conference for sickle cell and thalassaemia.

Co-founder of the sickle cell cohort research foundation, Nigeria (SCORE):

Co-chair Treatment Subcommittee of Consortium on Newborn Screening Africa (CONSA) and ASH Visitors training programme supervisor. The Consortium on Newborn Screening in Africa (CONSA) is an international network that seeks to demonstrate the benefits of newborn screening and early interventions for children with sickle cell disease (SCD) in sub-Saharan Africa.

Principal investigator, African Research and Innovative Initiative for sickle cell education: improving research for service (ARISE) EU, Africa (Nigeria, Kenya, Zambia and Angola), Lebanon and US institutions and national chief investigator multiple drug clinical trials in sickle cell disease, UK.

Further information

He has published over 120 peer review papers and edited a book and book chapters as well as a reviewer and editorial board member of high impact journals. He supervises Masters and PhD, KCL.

See a full publications list.

Selected publications

1: Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande LF, Kiyaga C, Chunda-Liyoka CM, Awuonda B, Ohene-Frempong K, Inusa BP, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EM. The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology. Blood Adv. 2022 Oct 20:bloodadvances.2022007698. doi: 10.1182/bloodadvances.2022007698. Epub ahead of print. PMID: 36264096.

2: Zuiani C, Arigliani M, Zubair R, Dogara LG, Castriotta L, Sunday AD, Audu RC, Dadan-Garba H, Sani Z, Inusa B, Cogo P. The impact of urbanization and wealth on house dust mite sensitization in children from north-central Nigeria. Ital J Pediatr. 2022 Aug 19;48(1):151. doi: 10.1186/s13052-022-01348-w. PMID: 35986417; PMCID: PMC9392306.

3: Arigliani M, Kirkham FJ, Sahota S, Riley M, Liguoro I, Castriotta L, Gupta A, Rees D, Inusa B, Aurora P. Lung Clearance Index May Detect Early Peripheral Lung Disease in Sickle Cell Anemia. Ann Am Thorac Soc. 2022 Sep;19(9):1507-1515. doi: 10.1513/AnnalsATS.202102-168OC. PMID: 35104199.

4: Strunk C, Tartaglione I, Piccone CM, Colombatti R, Andemariam B, Manwani D, Smith A, Haile H, Kim E, Wilson S, Asare EV, Rivers A, Farooq F, Urbonya R, Boruchov D, Boatemaa GD, Perrotta S, Ekem I, Sainati L, Rao S, Zempsky W, Sey F, Antwi-Boasiako C, Segbefia C, Inusa B, Campbell AD. Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort. Blood Cells Mol Dis. 2021 Dec;92:102612. doi:10.1016/j.bcmd.2021.102612. Epub 2021 Sep 21. PMID: 34564050; PMCID: PMC8643307.

5: Constantinou C, Payne N, van den Akker O, Inusa B. A qualitative exploration of health-related quality of life and health behaviours in children with sickle cell disease and healthy siblings. Psychol Health. 2021 Aug 2:1-22. doi:10.1080/08870446.2021.1955119. Epub ahead of print. PMID: 34339316.

6: Inusa BPD, Liguoro I, Tayo B, Booth C, Turner C, Dalton NR. Reliability of different estimated glomerular filtration rate as measures of renal function in children with sickle cell disease. Blood Cells Mol Dis. 2021 Nov;91:102590. doi:10.1016/j.bcmd.2021.102590. Epub 2021 Jul 7. PMID: 34256313.

7: Inusa BPD, Casale M, Campbell A, Archer N. Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? Lancet Haematol. 2021 May;8(5):e306-e307. doi: 10.1016/S2352-3026(21)00098-3. Epub 2021 Apr 7. PMID: 33838114.

8: Tartaglione I, Strunk C, Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Piccone CM, Manwani D, Boruchov D, Tavernier F, Farooq F, Akatue S, Oteng B, Urbonya R, Wilson S, Owda A, Bamfo R, Boatemaa GD, Rao S, Zempsky W, Sey F, Inusa BP, Perrotta S, Segbefia C, Campbell AD. Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort. Blood Cells Mol Dis. 2021 May;88:102531. doi: 10.1016/j.bcmd.2020.102531. Epub 2021 Jan 2. PMID: 33401140.

9: Strunk C, Campbell A, Colombatti R, Andemariam B, Kesse-Adu R, Treadwell M, Inusa BPD. Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings. BMC Proc. 2020 Dec 16;14(Suppl 20):21. doi: 10.1186/s12919-020-00204-1. PMID: 33323100; PMCID: PMC7739449.

10: Liguoro I, Arigliani M, Singh B, Van Geyzel L, Chakravorty S, Bossley C, Pelidis M, Rees D, Inusa BPD, Gupta A. Beneficial effects of adenotonsillectomy in children with sickle cell disease. ERJ Open Res. 2020 Oct 26;6(4):00071-2020. doi: 10.1183/23120541.00071-2020. PMID: 33263027; PMCID: PMC7682659.

11: Inusa BPD, Jacob E, Dogara L, Anie KA. Racial inequalities in access to care for young people living with pain due to sickle cell disease. Lancet Child Adolesc Health. 2021 Jan;5(1):7-9. doi: 10.1016/S2352-4642(20)30318-7. Epub 2020 Oct 13. PMID: 33065000.

12: Telfer P, De la Fuente J, Sohal M, Brown R, Eleftheriou P, Roy N, Piel FB, Chakravorty S, Gardner K, Velangi M, Drasar E, Shah F, Porter JB, Trompeter S, Atoyebi W, Szydlo R, Anie KA, Ryan K, Sharif J, Wright J, Astwood E, Nicolle CS, Webster A, Roberts DJ, Lugthart S, Kaya B, Awogbade M, Rees DC, Hollingsworth R, Inusa B, Howard J, Layton DM. Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients. Haematologica. 2020 Nov 1;105(11):2651-2654. doi: 10.3324/haematol.2020.259440. PMID: 33054122; PMCID: PMC7604629.

13: Campbell AD, Colombatti R, Andemariam B, Strunk C, Tartaglione I, Piccone CM, Manwani D, Asare EV, Boruchov D, Farooq F, Urbonya R, Boatemaa GD, Perrotta S, Sainati L, Rivers A, Rao S, Zempsky W, Sey F, Segbefia C, Inusa B, Antwi-Boasiako C. An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research. J Racial Ethn Health Disparities. 2021 Feb;8(1):99-106. doi: 10.1007/s40615-020-00762-2. Epub 2020 May 16. PMID: 32418182; PMCID: PMC7669607.

14: Inusa BPD, Stewart CE, Mathurin-Charles S, Porter J, Hsu LL, Atoyebi W, De Montalembert M, Diaku-Akinwumi I, Akinola NO, Andemariam B, Abboud MR, Treadwell M. Paediatric to adult transition care for patients with sickle cell disease: aglobal perspective. Lancet Haematol. 2020 Apr;7(4):e329-e341. doi:10.1016/S2352-3026(20)30036-3. PMID: 32220342.

15: Inusa BPD, Sainati L, MacMahon C, Colombatti R, Casale M, Perrotta S, Rampazzo P, Hemmaway C, Padayachee ST. An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective. J Clin Med. 2019 Dec 24;9(1):44. doi: 10.3390/jcm9010044. PMID: 31878188; PMCID: PMC7019609.

16: Inusa BPD, Colombatti R, Rees DC, Heeney MM, Hoppe CC, Ogutu B, Hassab HM, Zhou C, Yao S, Brown PB, Heath LE, Jakubowski JA, Abboud MR. Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study. J Clin Med. 2019 Nov 17;8(11):2009. doi: 10.3390/jcm8112009. PMID: 31744266; PMCID: PMC6912763.

17: Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, Atoyebi W. Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment. Int J Neonatal Screen. 2019 May 7;5(2):20. doi: 10.3390/ijns5020020. PMID: 33072979; PMCID: PMC7510211.

18: Arigliani M, Dogara LG, Zubair R, Castriotta L, Pusiol A, Zuiani C, Cogo P, Inusa B. Lung function impairment in pediatric patients with sickle cell anemia from Nigeria is associated with low steady state hemoglobin. Am J Hematol. 2019 Mar;94(3):E70-E71. doi: 10.1002/ajh.25373. Epub 2018 Dec 21. PMID: 30536980.

19: Inusa BPD, Anie KA, Lamont A, Dogara LG, Ojo B, Ijei I, Atoyebi W, Gwani L, Gani E, Hsu L. Utilising the 'Getting to Outcomes<sup>®</sup>' Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria. Int J Neonatal Screen. 2018 Nov 16;4(4):33. doi: 10.3390/ijns4040033. PMID: 33072954; PMCID: PMC7510187.